BASOLO, FULVIO
 Distribuzione geografica
Continente #
NA - Nord America 23.783
EU - Europa 11.510
AS - Asia 4.950
AF - Africa 535
SA - Sud America 102
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 14
Totale 40.913
Nazione #
US - Stati Uniti d'America 23.220
IT - Italia 3.676
SE - Svezia 2.469
CN - Cina 2.128
DE - Germania 1.853
SG - Singapore 1.164
BG - Bulgaria 1.099
TR - Turchia 738
GB - Regno Unito 650
CA - Canada 554
VN - Vietnam 425
AT - Austria 406
FI - Finlandia 379
UA - Ucraina 364
CI - Costa d'Avorio 317
HK - Hong Kong 238
RU - Federazione Russa 158
SN - Senegal 145
IN - India 136
CH - Svizzera 133
BR - Brasile 86
BE - Belgio 80
FR - Francia 77
NL - Olanda 48
NG - Nigeria 40
IR - Iran 20
JP - Giappone 20
PL - Polonia 18
AU - Australia 17
CZ - Repubblica Ceca 16
BJ - Benin 15
ES - Italia 15
KR - Corea 15
EU - Europa 14
RO - Romania 14
GR - Grecia 9
PK - Pakistan 9
JO - Giordania 7
MA - Marocco 7
RS - Serbia 7
ID - Indonesia 6
IE - Irlanda 6
IL - Israele 6
MY - Malesia 6
DK - Danimarca 5
EG - Egitto 5
IQ - Iraq 5
TW - Taiwan 5
CL - Cile 4
CY - Cipro 4
EC - Ecuador 4
HU - Ungheria 4
SA - Arabia Saudita 4
AR - Argentina 3
BD - Bangladesh 3
BN - Brunei Darussalam 3
MX - Messico 3
PT - Portogallo 3
BY - Bielorussia 2
EE - Estonia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LU - Lussemburgo 2
MT - Malta 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
MS - Montserrat 1
NP - Nepal 1
PH - Filippine 1
PY - Paraguay 1
SC - Seychelles 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 40.913
Città #
Fairfield 3.028
Woodbridge 2.474
Chandler 2.182
Houston 1.793
Ann Arbor 1.627
Ashburn 1.558
Seattle 1.276
Wilmington 1.119
Sofia 1.097
Cambridge 1.008
Beijing 722
New York 691
Milan 659
Singapore 561
Ottawa 516
Izmir 507
Boardman 505
Serra 499
Princeton 486
Lawrence 443
Jacksonville 435
Medford 393
Vienna 372
Santa Clara 356
Abidjan 317
Nanjing 315
Des Moines 257
Pisa 239
Florence 232
San Diego 199
Dearborn 189
Istanbul 187
London 148
Dong Ket 147
Dakar 145
Hong Kong 133
Frankfurt am Main 125
Rome 125
Bern 115
Nanchang 115
Bremen 114
Boulder 93
Falls Church 91
Ogden 90
Kunming 87
Shanghai 83
Brussels 75
Jüchen 68
Lancaster 68
Shenyang 65
Redwood City 63
Changsha 58
Los Angeles 56
Hebei 54
Washington 49
Naples 47
Fuzhou 46
Hefei 46
Nürnberg 46
Norwalk 45
Dallas 43
Tianjin 43
Jiaxing 40
Lagos 39
Pune 39
Bologna 37
Quanzhou 37
Munich 36
Hangzhou 35
Redmond 33
Jinan 32
Guangzhou 31
Orange 28
Düsseldorf 26
Zhengzhou 24
Chicago 23
Kocaeli 23
Marseille 23
Vicopisano 23
San Francisco 22
Auburn Hills 20
Phoenix 20
Indiana 19
Verona 19
Seacroft 18
Wuhan 18
Chengdu 17
Fremont 16
Helsinki 16
Hyderabad 16
Kent 16
Tappahannock 16
Cotonou 15
Palermo 15
Lanzhou 14
Toronto 14
Detroit 13
Lucca 13
Trieste 13
Turin 13
Totale 29.597
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 856
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 263
null 259
Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism due to MEN 1-Like syndrome 204
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES 197
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 193
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 189
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10 years follow up study 187
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 185
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 169
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 166
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 165
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 164
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 163
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 162
null 160
Picornavirus-induced immuno-suppression 157
null 157
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 156
Surgical treatment of pleural recurrence from thymoma 155
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 154
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 151
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 149
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 149
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 148
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 148
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 147
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 144
Ret Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center 144
KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) 142
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 142
PRODUCTIVE HIV-1 INFECTION OF NORMAL HUMAN MAMMARY EPITHELIAL-CELLS 140
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 140
Prevalence of papillary thyroid cancer (PTC) in patients affected by medullary thyroid cancer (MTC) 139
A proteomic approach to study parathyroid glands 138
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 138
Acute pressure overload induces oxidative stress and tPA expression in rat mesenteric small arteries 137
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 137
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 137
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 137
Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes 136
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 136
MULTIPLE ORGAN-REACTIVITY OF MONOCLONAL AUTOANTIBODIES TO MOUSE ERYTHROCYTES 135
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 134
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 130
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 130
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 128
DIABETES MELLITUS 127
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 127
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 127
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer 127
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients 126
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 124
Metastasis of renal cell carcinoma to the parathyroid gland 16 years after radical nephrectomy: A case report 124
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 124
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 123
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 122
miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features’ compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas 122
null 122
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease 122
Influence of T and N stages on long term survival in resectable small cell lung cancer 121
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 120
Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer 119
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 119
Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age 119
SYSTEMIC LYMPHOID ATROPHY IN COXSACKIE-VIRUS B3-INFECTED MICE - EFFECTS OF VIRUS AND IMMUNOPOTENTIATING AGENTS 118
Ectopic expression of bone sialoprotein in human thyroid cancer 118
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 118
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer 118
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 118
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 117
Intimal Sarcoma of the Descending Aorta Mimicking Aortitis 117
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 116
A microRNA signature for the differential diagnosis of salivary gland tumors 116
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 116
MATRIGEL PROMOTES RETINOBLASTOMA CELL-GROWTH INVITRO AND INVIVO 115
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 115
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 114
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 114
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 114
null 114
FR-MLV INFECTION INDUCES ERYTHROLEUKEMIA INSTEAD OF LYMPHOID LEUKEMIA IN MICE GIVEN PITUITARY GRAFTS 113
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 113
The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology 112
DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions 112
Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts 111
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 111
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 111
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma 111
Extensive clinical experience - Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma 110
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 110
A HUMAN MONOCLONAL AUTOANTIBODY ISOLATED FROM A PATIENT WITH INFECTIOUS-MONONUCLEOSIS REACTIVE WITH BOTH SELF ANTIGENS AND EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN (EBNA) 110
null 110
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine 110
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 110
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 110
Lipomatous hamartoma-like lesion of a bicuspid aortic valve: an incidental surgical finding 110
Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology 110
EVIDENCE OF A LOW PREVALENCE OF RAS MUTATIONS IN A LARGE MEDULLARY THYROID CANCER SERIES 109
Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes 109
Totale 14.272
Categoria #
all - tutte 125.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.428 0 0 0 0 807 900 926 663 775 544 649 164
2020/20213.654 298 246 235 184 370 189 294 386 354 317 234 547
2021/20225.364 124 221 151 396 995 831 163 236 282 264 293 1.408
2022/20237.123 893 961 516 643 756 892 101 578 1.202 64 438 79
2023/20244.486 477 417 484 361 638 841 191 157 145 116 180 479
2024/20252.419 125 575 154 911 654 0 0 0 0 0 0 0
Totale 41.769